GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
2019-03-27 $45.17 $45.47 $43.92 $44.02 246 872
2019-03-26 $45.01 $45.72 $44.59 $45.39 226 999
2019-03-25 $44.20 $45.12 $43.39 $44.88 228 787
2019-03-22 $46.87 $47.37 $44.10 $44.16 359 080
2019-03-21 $44.86 $47.13 $44.62 $47.07 321 480
2019-03-20 $46.34 $46.67 $44.59 $45.23 268 538
2019-03-19 $47.02 $47.24 $46.05 $46.27 190 691
2019-03-18 $46.94 $47.98 $46.29 $46.91 333 495
2019-03-15 $46.44 $47.61 $46.18 $47.13 1 422 193
2019-03-14 $46.60 $47.06 $46.03 $46.18 305 240
2019-03-13 $45.86 $46.92 $45.48 $46.63 250 775
2019-03-12 $46.38 $46.64 $45.47 $45.73 203 697
2019-03-11 $44.25 $46.42 $44.25 $46.38 366 814
2019-03-08 $43.72 $44.32 $43.35 $43.96 254 410
2019-03-07 $44.11 $44.87 $43.23 $44.14 315 924
2019-03-06 $46.30 $46.93 $44.08 $44.18 477 725
2019-03-05 $46.25 $47.25 $45.80 $46.25 460 949
2019-03-04 $46.23 $46.84 $44.97 $46.24 510 795
2019-03-01 $44.30 $46.02 $44.00 $45.94 427 775
2019-02-28 $45.50 $46.18 $41.39 $44.04 873 664
2019-02-27 $44.67 $46.10 $43.72 $45.88 590 027
2019-02-26 $43.04 $46.32 $42.82 $45.16 936 989
2019-02-25 $43.05 $43.87 $41.97 $42.29 535 419
2019-02-22 $42.02 $42.77 $41.88 $42.74 219 744
2019-02-21 $41.94 $42.64 $41.75 $41.98 239 371
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT